Meanwhile, high MAP17 (HR, 1.743; 95% CI, 1.152-2.639; p = 0.009), large tumor size (> 5 cm) (HR, 2.378; 95% CI, 1.490-3.797; p < 0.001), and elevated serum AST level (> 40 U/L) (HR, 2.014; 95% CI, 1.394-2.909; p < 0.001) were also identified as important independent predictors of OS for HCC patients (Table 4). Here, PDZK1IP1 is linked to hepatocellular carcinoma.